Skip to content

Vaginal and Oral Microbiome Crosstalk

EMMI - Emättimen Mikrobiomi - Emättimen ja Suun Limakalvojen Vuorovaikutus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02898818
Enrollment
520
Registered
2016-09-13
Start date
2017-04-19
Completion date
2027-09-30
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Vaginal Discharge

Brief summary

To study the vaginal and oral microbiome by swab samples. On selected cases, also papa smear will be studied.

Detailed description

To study the vaginal and oral microbiome by swab samples and on selected groups, by papa smear test, to find out the constitution of normal and vaginal microbiome and the cross-talk between oral and vaginal mucosa. To find out about the impact of human papilloma virus on the microbiome and vice versa.

Interventions

OTHERvaginal and oral swab sample, questionnaire

vaginal and oral swab sample and questionnaire

OTHERpapa smear

Papnicolaou Papa Smear test

Sponsors

Oulu University Hospital
CollaboratorOTHER
Turku University Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients coming to Turku University Hospital Dermato-Venereology or Gynaecology Departments or to family planning clinics in The wellbeing services county of Southwest Finland for previously mentioned reasons

Exclusion criteria

* those not meeting the criteria

Design outcomes

Primary

MeasureTime frameDescription
microbiome, papa smear5 yearsDifferences in microbiome and papa smear

Countries

Finland

Contacts

Primary ContactNiina K Hieta, MD, PhD
niina.hieta@tyks.fi2-3131620
Backup ContactKatja M Kero, Md, PhD
katja.kero@tyks.fi2-3130000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026